Short Interest in Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) Increases By 342.9%

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) was the target of a large growth in short interest in November. As of November 30th, there was short interest totalling 3,100 shares, a growth of 342.9% from the November 15th total of 700 shares. Based on an average daily volume of 9,000 shares, the days-to-cover ratio is currently 0.3 days.

Pharma-Bio Serv Stock Performance

Shares of PBSV stock remained flat at $0.50 on Wednesday. Pharma-Bio Serv has a 12-month low of $0.31 and a 12-month high of $1.09. The company has a 50-day simple moving average of $0.56 and a 200-day simple moving average of $0.60. The firm has a market cap of $11.48 million, a PE ratio of -16.67 and a beta of 0.56.

Pharma-Bio Serv (OTCMKTS:PBSV) last released its quarterly earnings data on Monday, September 16th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.04). Pharma-Bio Serv had a negative return on equity of 5.81% and a negative net margin of 7.81%. The business had revenue of $2.42 million during the quarter, compared to analysts’ expectations of $3.50 million.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.